The capital structure graph behind private markets. Who lent, to whom, under which sponsor, through which facility, how large the piece was, when it matures and what changed, with a filing behind every number. A BDC piece is that BDC's piece, a sum of pieces is a lower bound, and a sponsor is named with the evidence that names it.

Borrower

Avalo Therapeutics, Inc

Drug Discovery & Developmentgroup grade Aon a schedule nowsponsor Orbimed Advisors LLC carried
Also written as: 19; 2014; 8; Equity
Principal held
unknown
sum of BDC pieces, a lower bound
Fair value
$1,000
n/a on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
0
1 equity pieces beside them
Next maturity
unstated
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Jun 30, 2026
Events
0
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
No debt facility on the tape for this borrower; the BDC pieces are equity.
Equity pieces beside the debt: equity ($1,000 fair value, 1 BDC)
Lenders
every BDC piece at the latest quarter end
BDCInstrumentPrincipalFair valueRate
Hercules Capital, Inc.equity equity
Common Stock
n/a$1,000
0c
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20261$0$0n/a0
Mar 31, 20261$0$0n/a0
Dec 31, 20251$0$0n/a0
Sep 30, 20251$0$0n/a0
Jun 30, 20251$0$0n/a0
Mar 31, 20251$0$0n/a0
Dec 31, 20241$0$0n/a0
Sep 30, 20241$0$0n/a0
Jun 30, 20241$0$0n/a0
Mar 31, 20241$0$0n/a0
Dec 31, 20231$0$0n/a0
Sep 30, 20231$0$0n/a0
Jun 30, 20231$0$0n/a0
Mar 31, 20231$0$0n/a0
Dec 31, 20221$0$0n/a0
What changed
No non-routine event yet: the borrower has been held without a facility-level change since it appeared.
Every change including routine ones
Identity
Group key
AVALO THERAPEUTICSderivedthe codename stem after legal suffixes and deal words
Spellings
1 across 1 BDCderived
Industry
Drug Discovery & Developmentreportedas one filer wrote it